Vitamin supplements in the Era of SARS-Cov2 pandemic
DOI:
https://doi.org/10.30574/gscbps.2020.11.2.0114Keywords:
SARS-CoV-2 infection, COVID-19, Vitamin supplementsAbstract
Recently, the rapid and extensive spread of a novel human RNA betacoronavirus, known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is causing a worldwide public health emergency, originated in Wuhan, China. The disease caused by this new coronavirus, called "COVID-19", is very contagious. Although most of infected subjects are asymptomatic or present with mild flu-like symptoms, the rapid spread of the virus has resulted in a significant amount of serious interstitial pneumonia that may quickly develop into severe acute respiratory distress syndrome (ARDS), septic shock, sepsis-induced coagulopathy and fatal multiorgan dysfunction. Hence, the unabated spread of the disease demands an immediate need to explore all the plausible therapeutic and prophylactic strategies for reducing the high morbidity and mortality of this infection. At present, there is no vaccine or certainly effective antiviral treatment for human SARS-Cov-2 and the mainstay of clinical management is prevalently symptomatic treatment combined with a panel of drugs having variable and uncertain efficacy. Unfortunately, no many drugs have yet been approved to treat human SARS-Cov-2 infection and many agents are administered in off label route; several options are being studied to control or prevent clinical manifestations of this infection, including monoclonal antibodies, antiviral and anti-cytokine agents, antibiotics, and other drugs. Given that several vitamins are known to have antimicrobial properties and immunomodulatory activity, a potential role of vitamins in the COVID-19 treatment was investigated.
Metrics
References
Wang C, Horby PW, Hayden FG and Gao GF. (2020). A novel coronavirus outbreak of global health concern. Lancet, published online Jan 24.
Chaolin H, Yeming W. Xingwang L, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M0, Xiao Y, Gao H1, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J and Cao B. (2019). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet, 395, 497-506.
Vaira LA, Salzano G, Deiana G and De Riu G. (2020). Anosmia and ageusia: common findings in COVID-19 patients. Laryngoscope.
Gane SB, Kelly C and Hopkins C. (2020). Isolated sudden onset anosmia in COVID-19 infection. A novel syndrome? Rhinology.
Zhang C, Wu Z, Li JW, Zhao H and Wang GQ. (2020). The cytokine release syndrome (CRS) of severe COVID-19 and Interleukin-6 receptor (IL-6R) antagonist Tocilizumab may be the key to reduce the mortality. International Journal of Antimicrobial Agents, 105954.
Iba T, Levy JH, Warkentin TE, Thachil J, van der Poll T and Levi M. (2019). Diagnosis and management of sepsis-induced coagulopathy and disseminated intravascular coagulation. Journal of Thrombosis and Haemostasis, 17(11), 1989–1994.
Levi M and van der Poll T. (2017). Coagulation and sepsis. Thrombosis Research, 149, 38–44.
Tang N, Li D, Wang X and Sun Z. (2020). Abnormal Coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. Journal of Thrombosis and Haemostasis, 18(4), 844-847.
Klok FA, Kruip MJHA, van der Meer NJM, Arbous MS, Gommers DAMPJ, Kant KM, Kaptein FHJ, van Paassen J, Stals MAM, Huisman MV and Endeman H. (2020). Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thrombosis Research, S0049-3848(20)30120-1.
Rotzinger DC, Beigelman-Aubry C, von Garnier C and Quanadli SD. (2020). Pulmonary embolism in patients with COVID-19: Time to change the paradigm of computed tomography. Thrombosis Research 190, P58-59.
Cui S, Chen S, Li X, Liu S and Wang F.J (2020). Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. Journal of Thrombosis and Haemostasis.
Luo W, Yu H, Gou J, Li X, Sun Y, Li J and Liu L. (2020). Clinical Pathology of Critical Patient with Novel Coronavirus Pneumonia (COVID-19). Preprints, 2020020407.
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J and Cao B. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet, 395(10223), 497-506.
Lillicrap D. (2020). Disseminated intravascular coagulation in patients with 2019-nCoV pneumonia. Journal of Thrombosis and Haemostasis, 18(4), 786-787.
Zumla A, Hui DS, Azhar EI, Memish ZA and Maeurer M. (2020). Reducing mortality from 2019-nCoV: host-directed therapies should be an option. Lancet, 395, e35-e36.
Tong TR. (2009). Drug targets in severe acute respiratory syndrome (SARS) virus and other coronavirus infections. Infectious Disorders - Drug Targets, 9(2), 223-45.
Choudhry H, Bakhrebah MA, Abdulaal WH, Zamzami MA, Baothman OA, Hassan MA, Zeyadi M, Helmi N, Alzahrani F, Ali A, Zakaria MK, Kamal MA, Warsi MK, Ahmed F, Rasool M and Jamal MS. (2019). Middle East respiratory syndrome: pathogenesis and therapeutic developments. Future Virolology, 14(4), 237-246.
Carr AC, Rosengrave PC, Bayer S, Chambers S, Mehrtens J and Shaw GM. (2017). Hypovitaminosis C and vitamin C deficiency in critically ill patients despite recommended enteral and parenteral intakes. Critical Care, 21, 300.
Hemilä H. (2017). Vitamin C and Infections. Nutrients, 9(4), 339.
Marik PE. (2018). Vitamin C for the treatment of sepsis: the scientific rationale. Pharmacology & Therapeutics, 189, 63–70.
Fowler AA 3rd, Truwit JD, Hite RD, Morris PE, DeWilde C, Priday A, Fisher B, Thacker LR 2nd, Natarajan R, Brophy DF, Sculthorpe R, Nanchal R, Syed A, Sturgill J, Martin GS, Sevransky J, Kashiouris M, Hamman S, Egan KF, Hastings A, Spencer W, Tench S, Mehkri O, Bindas J, Duggal A, Graf J, Zellner S, Yanny L, McPolin C, Hollrith T, Kramer D, Ojielo C, Damm T, Cassity E, Wieliczko A and Halquist M. (2019). Effect of vitamin c infusion on organ failure and biomarkers of inflammation and vascular injury in patients with sepsis and severe acute respiratory failure: the CITRIS-ALI Randomized clinical trial. Journal of the American Medical Association, 322, 1261–1270.
Gao YL, Lu B, Zhai JH, Liu YC, Qi HX, Yao Y, Chai YF and Shou ST. (2017). The Parenteral Vitamin C Improves Sepsis and Sepsis-Induced Multiple Organ Dysfunction Syndrome via Preventing Cellular Immunosuppression. Mediators of Inflammation, 4024672.
While LA, Freeman CY, Forrester BD and Chappell WA. (1986). In vitro effect of ascorbic acid on infectivity of herpesviruses and paramyxoviruses. Journal of Clinical Microbiology, 24, 527–531.
Furuya A, Uozaki M, Yamasaki H, Arakawa T, Arita M and Koyama AH. (2008). Antiviral effects of ascorbic and dehydroascorbic acids in vitro. International Journal of Molecular Medicine, 22(4), 541–5.
Sorice A, Guerriero E, Capone F, Colonna G, Castello G and Costantini S. (2014). Ascorbic acid: its role in immune system and chronic inflammation diseases. Mini Reviews in Medical Chemistry, 14(5), 444-52.
Huijskens MJ , Walczak M, Sarkar S, Atrafi F, Senden-Gijsbers BL, Tilanus MG, Bos G M, Wieten L and Germeraad WT. (2015). Ascorbic acid promotes proliferation of natural killer cell populations in culture systems applicable for natural killer cell therapy. Cytotherapy, 17(5), 613–20.
Manning J , Mitchell B, Appadurai DA, Shakya A, Pierce LJ, Wang H, Nganga V, Swanson PC, May JM, Tantin D and Spangrude GJ. (2013). Vitamin C promotes maturation of T-cells. Antioxidant Redox Signaling, 19(17), 2054–67.
Webb AL and Villamor E. (2007). Update: effects of antioxidant and non-antioxidant vitamin supplementation on immune function. Nutrition Reviews, 65(5), 181–217.
Gorkom GNY, Klein Wolterink RGJ, Van Elssen C, Wieten L, Germeraad WTV and Bos GMJ. (2018). Influence of Vitamin C on Lymphocytes: An Overview. Antioxidants, 7(3), pii: E41.
Carr AC. (2017). Vitamin C and Immune Function. Nutrients, 9, 1211.
Kim Y, Kim H, Bae S, Choi J, Lim SY, Lee N, Kong JM, Hwang YI, Kang JS and Lee WJ. (2013). Vitamin C is an essential factor on the anti-viral immune response through the production of interferon-alpha/beta at the initial stage of influenza A virus (H3N2) infection. Immune Network, 13, 70–74.
Tveden-Nyborg P and Lykkesfeldt J. (2013). Does vitamin C deficiency increase lifestyle-associated vascular disease progression? Evidence based on experimental and clinical studies. Antioxidant & Redox Signaling, 19(17), 2084-104.
Lykkesfeldt J, Michels AJ and Frei B. (2014). Vitamin C. Advances in Nutrition, 5(1), 16-8.
Kim H, Jang M, Kim Y, Choi J, Jeon J, Kim J, Hwang YI, Kang JS and Lee WJ. (2016). Red ginseng and vitamin C increase immune cell activity and decrease lung inflammation induced by influenza A virus/H1N1 infection. Journal of Pharmacy and Pharmacology, 68(3), 406–20.
Hemila H. (1997). Vitamin C intake and susceptibility to pneumonia. The Pediatric Infectious Disease Jornal, 16, 836‐837.
Institute of Medicine (US). (2000). Panel on Dietary Antioxidants and Related Compounds. Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids. Washington (DC): National Academies Press (US).
Levine M, Wang Y, Padayatty SJ and Morrow J. (2001). A new recommended dietary allowance of vitamin C for healthy young women. Proceedings of National Academy of Sciences of the United States of America, 98(17), 9842–6.
Frei B, Birlouez I and Lykkesfeldt J. (2012). What is the optimum intake of vitamin C in humans? Critical Reviews in Food Science and Nutrition, 52, 815–29.
Carr AC. (2020). A new clinical trial to test high-dose vitamin C in patients with COVID-19. Critical Care, 24(1), 133.
Aranow C. (2011). Vitamin D and the immune system. Journal of Investigative Medicine, 59(6), 881-6.
Watkins RR, Lemonovich TL and Salata RA. (2015). An update on the association of vitamin D deficiency with common infectious diseases. Canadian Journal of Physiology and Pharmacology, 93(5), 363-8.
Asbaghi O, Sadeghian M, Mozaffari-Khosravi H, Maleki V, Shokri A, Hajizadeh-Sharafabad F, Alizadeh, M and Sadeghi O. (2020). The effect of vitamin d-calcium co-supplementation on inflammatory biomarkers: A systematic review and meta-analysis of randomized controlled trials. Cytokine, 129, 155050.
Institute of Medicine (US) Committee to Review Dietary Reference Intakes for Vitamin D and Calcium, Ross AC, Taylor CL, Yaktine AL, Del Valle HB, eds. (2011). Dietary Reference Intakes for Calcium and Vitamin D. Washington (DC): National Academies Press (US), 2011.
Aloia JF. (2011). Clinical Review: The 2011 report on dietary reference intake for vitamin D: where do we go from here? The Journal of Clinical Endocrinology and Metabolism, 96(10), 2987-96.
Tangpricha V, Pearce EN, Chen TC and Holick MF. (2002). Vitamin D in- sufficiency among free‐living healthy young adults. American Jornal of Medicine, 112, 659‐662.
Holick MF. (2004). Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. American Journal of Clinical Nutrition 80, 1678S‐1688S.
Taylor PN and Davies JS. (2018). A review of the growing risk of vitamin D toxicity from inappropriate practice. British Journal of Clinical Pharmacology, 84(6), 1121–1127.
Galior K, Grebe S and Singh R. (2018). Development of Vitamin D Toxicity from Overcorrection of Vitamin D Deficiency: A Review of Case Reports. Nutrients, 10(8), 953.
Colombo ML. (2010). An update on vitamin E, tocopherol and tocotrienol-perspectives. Molecules, 15(4), 2103–2113.
Jiang Q. (2014). Natural forms of vitamin E: metabolism, antioxidant, and anti-inflammatory activities and their role in disease prevention and therapy. Free Radical Biology & Medicine, 72, 76–90.
Clarke MW, Burnett JR and Croft KD. (2008). Vitamin E in human health and disease. Critical Reviews in Clinical Laboratory Science, 45(5), 417–450.
Roghani M and Behzadi G. (2001). Neuroprotective effect of vitamin E on the early model of Parkinson's disease in rat: behavioral and histochemical evidence. Brain Research, 892(1), 211–217.
Cherubini A, Martin A, Andres-Lacueva C, Di Iorio A, Lamponi M, Mecocci P, Bartali B, Corsi A, Senin U and Ferrucci L. (2005). Vitamin E levels, cognitive impairment and dementia in older persons: the InCHIANTI study. Neurobiology of Aging, 26(7), 987–994.
Beharka A, Redican S, Leka L and Meydani SN. (1997). Vitamin E status and immune function. Methods in Enzymology, 282, 247–263.
Eskew ML, Scholz RW, Reddy CC, Todhunter DA and Zarkower A. (1985). Effects of vitamin E and selenium deficiencies on rat immune function. Immunology 54, 173–180.
Coquette A, Vray B and Vanderpas J. (1986). Role of vitamin E in the protection of the resident macrophage membrane against oxidative damage. Archives internationales de physiologie et de biochimie, 94, S29–S34.
Han SN and Meydani SN. (2006). Impact of vitamin E on immune function and its clinical implications. Expert Review of Clinical Immunology, 2, 561–567.
Tengerdy RP, Henzerling RH, Brown GL and Mathias MM. (1973). Enhancement of the humoral immune response by vitamin E. International Archives of Allergy and Applied Immunology, 44, 221–232.
Meydani SN, Barklund MP, Liu S, Meydani M, Miller RA, Cannon JG, Morrow FD, Rocklin R and Blumberg JB. (1990). Vitamin E supplementation enhances cell-mediated immunity in healthy elderly subjects. American Journal of Clinical Nutrition, 52, 557–563.
Meydani SN, Meydani M, Blumberg JB, Leka LS, Siber G, Loszewski R, Thompson C, Pedrosa MC, Diamond RD and Stollar BD. (1997). Vitamin E supplementation and in vivo immune response in healthy elderly subjects a randomized controlled trial. The Journal of American Medical Association, 277, 1380–1386.
Wu D and Meydani SN. (2008). Age-associated changes in immune and inflammatory responses: impact of vitamin E intervention. Journal of Leukocyte Biology, 84, 900–914.
Moriguchi S, Miwa H, Okamura M, Maekawa K, Kishino Y and Maeda K. (1993). Vitamin E is an important factor in t cell differentiation in thymus of f344 rats. Journal of Nutrition Science and Vitaminology, 39, 451–463.
Meydani SN, Meydani M, Verdon CP, Shapiro AA, Blumberg JB and Hayes KC. (1986). Vitamin E supplementation suppresses prostaglandin e1(2) synthesis and enhances the immune response of aged mice. Mechanisms of Ageing and Development, 34, 191–201.
Corwin LM and Shloss J. (1980). Influence of vitamin E on the fitogeni response of murine lymphoid cells. Journal of Nutrition. 110, 916–923.
Wang Y and Watson RR. (1994) Vitamin E supplementation at various levels alters cytokine production by thymocytes during retrovirus infection causing murine aids. Thymus, 22, 153–165.
Miller ME. (1979). Phagocytic function in the same neonate: selected aspects. Pediatrics, 64, 5709–5712.
Baehner RL, Boxer LA, Allen JM and Davis J. (1977). Autooxidation as a basis for altered function by polymorphonuclear leukocytes. Blood, 50, 327–335.
Prasad JS. (1980). Effect of vitamin E supplementation on leukocyte function. American Journal of Clinical Nutrition, 33, 606–608.
De la Fuente M, Hernanz A, Guayerbas N, Victor VM and Arnalich F. (2008). Vitamin E ingestion improves several immune functions in elderly men and women. Free Radical Research, 42, 272–280.
Neupane B, Walter SD, Krueger P, Marrie T and Loeb M. (2010). Predictors of inhospital mortality and re-hospitalization in older adults with community acquired pneumonia: a prospective cohort study. BMC Geriatriatrics, 10, 22.
Meydani SN, Leka LS, Fine BC, Dallal GE, Keusch GT, Singh MF and Hamer DH. (2004). Vitamin E and respiratory tract infections in elderly nursing home residents: a randomized controlled trial. The Journal of American Medical Association, 292(7), 828–836.
Graat JM, Schouten EG and Kok FJ. (2002). Effect of daily vitamin E and multivitamin-mineral supplementation on acute respiratory tract infections in elderly persons: a randomized controlled trial. The Journal of American Medical Association, 288, 715–721.
Hemila H. (2016). Vitamin E administration may decrease the incidence of pneumonia in elderly males. Clinical Interventions in Aging, 11, 1379–1385.
Hemila H, Virtamo J, Albanes D and Kaprio J. (2006). The effect of vitamin E on common cold incidence is modified by age, smoking and residential neighborhood. Journal of the American College of Nutrition, 25, 332–339.
Mocchegiani E, Costarelli L, Giacconi R, Malavolta M, Basso A, Piacenza F, Ostan R, Cevenini E, Gonos ES, Franceschi C and Monti D. (2014). Vitamin E-gene interactions in aging and inflammatory agerelated diseases: implications for treatment. A systematic review. Ageing Research Reviews, 14, 81–101.
Kowdley KV, Mason JB, Meydani SN, Cornwall S and Grand RJ. (1992). Vitamin E deficiency and impaired cellular immunity related to intestinal fat malabsorption. Gastroenterology, 102, 2139–2142.
Traber GM and Sies H. (1996). Vitamin E in humans: demand and delivery. Annual Review of Nutrition, 6, 321-47.
Muller DP and Goss-Sampson MA. (1990). Neurochemical, neurophysiological, and neuropathological studies in vitamin E deficiency. Critical Reviews in Neurobiology, 5(3), 239-63.
Piroddi M, Albini A, Fabiani R, Giovannelli L, Luceri C, Natella F, Rosignoli P, Rossi T, Taticchi A, Servili M and Galli F . (2017). Nutrigenomics of extra-virgin olive oil: A review. Biofactors, 43(1), 17-41.
Traber MG and Manor D. (2012). Vitamin E. Advances in Nutrition, 3(3), 330–331.
EFSA NDA Panel (EFSA Panel on Dietetic Products, Nutrition and Allergies. (2015). Scientific Opinion on Dietary Reference Values for vitamin E as α-tocopherol. European Food Safety Authority Journal, 13(7), 4149, 72.
Bates CJ. (1995). Vitamin A. Lancet, 345(8941), 31–35.
Ross AC and Ternus ME. (1993). Vitamin A as a hormone: recent advances in understanding the actions of retinol, retinoic acid, and beta carotene. Journal of the American Dietetic Association, 93(11), 1285–1292.
Harrison EH and Curley RW Jr. (2016). Carotenoids and Retinoids: Nomenclature, Chemistry, and Analysis. Subcell Biochem, 81, 1–19.
Belyaeva OV, Adams MK, Popov KM and Kedishvili NY. (2019). Generation of Retinaldehyde for Retinoic Acid Biosynthesis. Biomolecules, 10(1), 5.
Ott DB and Lachance PA. (1979). Retinoic acid--a review. American Journal of Clinical Nutrition, 32(12), 2522–2531.
Kedishvili NY. (2016). Retinoic Acid Synthesis and Degradation. Subcellular Biochemistry, 81, 127–161.
Clagett-Dame M and Knutson D. (2011). Vitamin A in reproduction and development. Nutrients, 3, 385–428.
Chen W and Chen G. (2014). The Roles of Vitamin A in the Regulation of Carbohydrate, Lipid, and Protein Metabolism. Journal of Clinical Medicine, 3(2), 453-79.
Conaway HH, Henning P and Lerner UH. (2013). Vitamin a metabolism, action, and role in skeletal homeostasis. Endocrine Reviews, 34(6), 766-97.
Shearer KD, Stoney PN, Morgan PJ and McCaffery PJ. (2012). A vitamin for the brain. Trends in Neurosciences, 35(12), 733-41
Zhong M, Kawaguchi R, Kassai M and Sun H. (2012). Retina, retinol, retinal and the natural history of vitamin A as a light sensor. Nutrients, 4(12), 2069-96.
Eggersdorfer M and Wyss A. (2018). Carotenoids in human nutrition and health. Archives of Biochemistry and Biophysics, 652, 18–26.
Larange A and Cheroutre H. (2016). Retinoic Acid and Retinoic Acid Receptors as Pleiotropic Modulators of the Immune System. Annual Review of Immunology, 34, 369-94.
Brown CC and Noelle RJ. (2015).Seeing through the dark: New insights into the immune regulatory functions of vitamin A. European Journal of Immunology, 45(5), 1287-95.
Huang Z, Liu Y, Qi G, Brand D and Zheng SG. (2018). Role of Vitamin A in the Immune System. Journal of Clinical Medicine, 7(9), 258.
Ross AC. (2012). Vitamin A and retinoic acid in T cell-related immunity. American Journal of Clinical Nutrition, 96(5), 1166S–72S.
Stephensen CB. (2001). Vitamin A, infection, and immune function. Annual Review of Nutrition, 21, 167–92.
Bono MR, Tejon G, Flores-Santibañez F, Fernandez D, Rosemblatt M and Sauma D. (2016). Retinoic Acid as a Modulator of T Cell Immunity. Nutrients, 8(6), 349.
Xiao S, Jin H, Korn T, Liu SM, Oukka M, Lim B and Kuchroo vK. (2008). Retinoic acid increases Foxp3+ regulatory T cells and inhibits development of Th17 cells by enhancing TGF-beta-driven Smad3 signaling and inhibiting IL-6 and IL-23 receptor expression. Journal of Immunology, 181(4), 2277-2284.
Penkert RR, Jones BG, Häcker H, Partridge JF and Hurwitz JL. (2017). Vitamin A differentially regulates cytokine expression in respiratory epithelial and macrophage cell lines. Cytokine, 91, 1–5.
Mora JR, Iwata M and von Andrian UH. (2008). Vitamin effects on the immune system: vitamins A and D take centre stage. Nature Reviews Immunolology, 8(9), 685–698.
Cassani B, Villablanca EJ, De Calisto J, Wang S and Mora JR. (2012). Vitamin A and immune regulation: role of retinoic acid in gut-associated dendritic cell education, immune protection and tolerance. Molecular Aspects of Medicine, 33(1), 63–76.
Villamor E and Fawzi WW. (2005). Effects of vitamin a supplementation on immune responses and correlation with clinical outcomes. Clinical Microbiology Reviews, 18(3), 446–464.
Sommer A, Djunaedi E, Loeden AA, Tarwotjo I, West K JR, Tilden R and Mele L. (1986). Impact of Vitamin A supplementation on childhood mortality. Lancet, 327, 1169–1173.
Semba RD. (1999). Vitamin A and immunity to viral, bacterial and protozoan infections. Proceedings of the Nutrition Society, 58, 719–27.
Villamor E, Mbise R, Spiegelman D, Hertzmark E, Fataki M, Peterson KE, Ndossi G and Fawzi WW. (2002). Vitamin A supplements ameliorate the adverse effect of HIV‐1, malaria, and diarrheal infections on child growth. Pediatrics, 109, (1)e6.
Semba RD. (1999). Vitamin A as “Anti-Infective” Therapy, 1920–1940. Journal of Nutrition, 129(4), 783–791.
Office of Dietary Supplements, National Institutes of Health. (2017). Vitamin A.
Zinder R, Cooley R, Vlad LG and Molnar JA. Vitamin A and Wound Healing. Nutrition in Clinical Practice, 34(6), 839–849.
Institute of Medicine (US) Panel on Micronutrients. (2001). Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc. Washington (DC): National Academies Press (US), 4, 82.
Ross AC (2010). Diet in Vitamin A Research. Methods in Molecular Biology.
Xavier AA and Pérez-Gálvez A. (2016) Carotenoids as a Source of Antioxidants in the Diet. Subcellular Biochemistry, 79, 359-75.
Hamishehkar H, Ranjdoost F, Asgharian P, Mahmoodpoor A and Sanaie S. (2016). Vitamins, Are They Safe? Advanced Pharmaceutical Bullettin, 6(4), 467–477.
Penniston KL and Tanumihardjo SA. (2006). The acute and chronic toxic effects of vitamin A. American Journal of Clinical Nutrition, 83(2), 191–201.
Jee J, Hoet AE, Azevedo MP, Vlasova AN, Loerch SC, Pickworth CL, Hanson J and Saif LJ. (2013). Effects of dietary vitamin A content on antibody responses of feedlot calves inoculated intramuscularly with an inactivated bovine coronavirus vaccine. American Journal of Veterinary Research, 74, 1353‐1362.
West CE, Sijtsma SR, Kouwenhoven B, Rombout JH and van der Zijpp AJ. (1992). Epithelia‐damaging virus infections affect vitamin A status in chickens. Journal of Nutrition, 122, 333‐339.
Depeint F, Bruce WR, Shangari N, Mehta R and O’Brien PJ. (2006). Mitochondrial function and toxicity: role of the B vitamin family on mitochondrial energy metabolism. Chemico-Biological Interactions, 163(1-2), 94-112.
Mikkelsen K and Apostolopoulos V. (2018). B Vitamins and Ageing. Subcellular Biochemistry, 90, 451-470.
Young LM, Pipingas A, White DJ, Gauci S and Scholey A. (2019). A Systematic Review and Meta-Analysis of B Vitamin Supplementation on Depressive Symptoms, Anxiety, and Stress: Effects on Healthy and 'At-Risk' Individuals. Nutrients, 11(9), 2232.
Axelrod AE. (1981). Role of the B vitamins in the immune response. Advances in Experimental Medicine and Biology, 135, 93–106.
Wintergerst ES, Maggini S and Hornig DH. (2007). Contribution of selected vitamins and trace elements to immune function. Annals of Nutrition and Metabolism, 51(4), 301-323.
Tamura J, Kubota K, Murakami H, Sawamura M, Matsushima T, Tamura T, Saitoh T, Kurabayshi H and Naruse T. (1999). Immunomodulation by vitamin B12: augmentation of CD8+ T lymphocytes and natural killer (NK) cell activity in vitamin B12-deficient patients by methyl-B12 treatment. Clinical & Experimental Immunology, 116(1), 28-32.
Doke S, Inagaki N, Hayakawa T and Tsuge H. (1998). Effects of vitamin B6 deficiency on cytokine levels and lymphocytes in mice. Bioscience, Biotechnology, and Biochemistry, 62(5), 1008-1010.
Qian B, Shen S, Zhang J and Jing P. (2017). Effects of vitamin B6 deficiency on the composition and functional potential of T cell populations. Journal of Immunology Research, 20172197975.
Partearroyo T, Úbeda N, Montero A, Achón M and Varela-Moreiras G. (2013). Vitamin B(12) and folic acid imbalance modifies NK cytotoxicity, lymphocytes B and lymphoprolipheration in aged rats. Nutrients, 5(12), 4836-4848.
Doke S, Inagaki N, Hayakawa T and Tsuge H. (1997). Effect of vitamin B6 deficiency on an antibody production in mice. Bioscience, Biotechnology, and Biochemistry, 61(8), 1331-1336.
Chandra RK, Heresi G and Au B. (1980). Serum thymic factor activity in deficiencies of calories, zinc, vitamin A and pyridoxine. Clinical & Experimental Immunology, 42(2), 332-335.
Qian B, Shen S, Zhang J and Jing P. (2017). Effects of Vitamin B6 Deficiency on the Composition and Functional Potential of T Cell Populations. Journal of Immunology Research, 2197975.
Friso S, Jacques PF, Wilson PW, Rosenberg IH and Selhub J. (2001). Low circulating vitamin B6 is associated with elevation of the inflammation marker C-reactive protein independently of plasma homocysteine levels. Circulation, 103, 2788–2791.
Friso S, Girelli D, Martinelli N, Olivieri O, Lotto V, Bozzini C, Pizzolo F, Faccini G, Beltrame F and Corrocher R. (2004). Low plasma vitamin B-6 concentrations and modulation of coronary artery disease risk. American Journal of Clinical Nutrition, 79, 992–998.
Courtemanch, C, Elson-Schwab I, Mashiyama ST, Kerry N and Ames BN. (2004). Folate deficiency inhibits the proliferation of primary human CD8+ T lymphocytes in vitro. Journal of Immunology, 173(5), 3186-3192.
Wu CH, Huang TC and Lin BF. (2017). Folate deficiency affects dendritic cell function and subsequent T helper cell differentiation. The Journal of Nutritional Biochemistry, 41, 65-72.
Shane B. (2008). Folate and vitamin B12 metabolism: overview and interaction with riboflavin, vitamin B6, and polymorphisms. Food and Nutrition Bullettin, 29(2 Suppl), S5–S19.
Troen AM, Mitchell B, Sorensen B, Wener MH, Johnston A, Wood B, Selhub J, McTiernan A, Yasui Y, Oral E, Potter JD and Ulrich CM. (2006). Unmetabolized folic acid in plasma is associated with reduced natural killer cell cytotoxicity among post- menopausal women. Journal of Nutrition, 136(1), 189-194.
Planells E, Sánchez C, Montellano MA, Mataix J and Llopis J. (2003). Vitamins B6 and B12 and folate status in an adult Mediterranean population. European Journal of Clinical Nutrition, 57(6), 777-785.
Morris MS, Picciano MF, Jacques PF and Selhub J. (2003). Plasma pyridoxal 5′-phosphate in the US population: the National Health and Nutrition Examination Survey, 2003-2004. American Journal of Clinical Nutrition, 87(5), 1446-1454.
McLean E, de Benoist B and Allen LH. (2008). Review of the magnitude of folate and vitamin B12 deficiencies worldwide. Food and Nutrition Bullettin, 29(2) (Suppl.), S38-S51.
Wong CW. (2015). Vitamin B12 deficiency in the elderly: is it worth screening? Hong Kong Medical Journal, 21(2), 155-164.
Dhonukshe-Rutten RAM, de Vries JHM, de Bree A, van der Put N, van Staveren WA and de Groot LC. (2009). Dietary intake and status of folate and vitamin B12 and their association with homocysteine and cardiovascular disease in European populations. European Journal of Clinical Nutrition, 63(1), 18-30.
Pawlak R. (2015). Is vitamin B12 deficiency a risk factor for cardiovascu- lar disease in vegetarians? American Journal of Preventive Medicine, 48(6), e11-e26.
Kjeldby IK, Fosnes GS, Ligaarden SC and Farup PG. (2013). Vitamin B6 deficiency and diseases in elderly people--a study in nursing homes. BMC Geriatrics, 13, 13.
Keil SD, Bowen R and Marschner S. (2016). Inactivation of Middle East respiratory syndrome coronavirus (MERS‐CoV) in plasma products using a riboflavin‐based and ultraviolet light‐based photochemical treatment. Transfusion, 56, 2948‐2952.
Kyme P, Thoennissen NH, Tseng CW, Thoennissen GB, Wolf AJ, Shimada K, Krug UO, Lee K, Müller-Tidow C, Berdel WE, Hardy WD, Gombart AF, Koeffler HP and Liu GY. (2012). C/EBPepsilon mediates nicotinamide‐enhanced clearance of Staphylococcus aureus in mice. Journal of Clinical Investigation, 122, 3316‐3329.
Sankar MJ, Chandrasekaran A, Kumar P, Thukral A, Agarwal R and Paul VK. (2016). Vitamin K prophylaxis for prevention of vitamin K deficiency bleeding: a systematic review. Journal of Perinatology, 36 Suppl 1(Suppl 1), S29–S35.
Shearer MJ, Fu X and Booth SL. (2012). Vitamin K nutrition, metabolism, and requirements: current concepts and future research. Advances in Nutrition, 3(2), 182–195.
Verhoef TI, Redekop WK, Daly AK, van Schie RM, de Boer A and Maitland-van der Zee AH. (2014). Pharmacogenetic-guided dosing of coumarin anticoagulants: algorithms for warfarin, acenocoumarol and phenprocoumon. British Journal of Clinical Pharmacology, 77(4), 626–641.
Witt DM, Nieuwlaat R, Clark NP, Ansell J, Holbrook A, Skov J, Shehab N, Mock J, Myers T, Dentali F, Crowther MA, Agarwal A, Bhatt M, Khatib R, Riva JJ, Zhang Y and Guyatt G. (2018). American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy. Blood Advances, 2(22), 3257–3291.
Barcellona D, Fenu L and Marongiu F. (2017). Point-of-care testing INR: an overview. Clin Chem Lab Med, 55(6), 800–805.
Booth SL. (2012). Vitamin K: food composition and dietary intakes. Food & Nutrition Research, 56.
Trumbo P, Yates AA, Schlicker S and Poos M. (2001). Dietary reference intakes: vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc. Journal of American Dietetic Association, 101(3), 294–301.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
